Hologic Balance Sheet Health

Financial Health criteria checks 6/6

Hologic has a total shareholder equity of $4.7B and total debt of $2.6B, which brings its debt-to-equity ratio to 55%. Its total assets and total liabilities are $8.5B and $3.8B respectively. Hologic's EBIT is $921.5M making its interest coverage ratio -49. It has cash and short-term investments of $1.9B.

Key information

55.0%

Debt to equity ratio

US$2.56b

Debt

Interest coverage ratio-49x
CashUS$1.94b
EquityUS$4.65b
Total liabilitiesUS$3.82b
Total assetsUS$8.47b

Recent financial health updates

Recent updates

Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Apr 19
Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Apr 05
Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Mar 20
Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Feb 22
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Hologic: Prospects For Growth As Headwinds Disappear

Feb 11

We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Feb 09
We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

Feb 06
Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

Jan 29
We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Dec 30
The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

Dec 11
Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Nov 08
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Oct 25
Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Sep 28
Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

Aug 29
Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Jul 31
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Jul 18
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Jun 21
Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

May 22
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Apr 25
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Apr 10
What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Mar 13
Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Feb 14
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Jan 18
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Is Now The Time To Look At Buying Hologic, Inc. (NASDAQ:HOLX)?

Jan 03
Is Now The Time To Look At Buying Hologic, Inc. (NASDAQ:HOLX)?

Shareholders Would Enjoy A Repeat Of Hologic's (NASDAQ:HOLX) Recent Growth In Returns

Dec 02
Shareholders Would Enjoy A Repeat Of Hologic's (NASDAQ:HOLX) Recent Growth In Returns

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Oct 12
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Sep 27
Is Hologic, Inc. (NASDAQ:HOLX) Potentially Undervalued?

Hologic announces $1B share buyback program

Sep 26

We Like Hologic's (NASDAQ:HOLX) Returns And Here's How They're Trending

Aug 27
We Like Hologic's (NASDAQ:HOLX) Returns And Here's How They're Trending

Hologic cut to Neutral at BTIG on macro concerns

Jul 18

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Jul 11
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Financial Position Analysis

Short Term Liabilities: HOLX's short term assets ($3.5B) exceed its short term liabilities ($899.0M).

Long Term Liabilities: HOLX's short term assets ($3.5B) exceed its long term liabilities ($2.9B).


Debt to Equity History and Analysis

Debt Level: HOLX's net debt to equity ratio (13.4%) is considered satisfactory.

Reducing Debt: HOLX's debt to equity ratio has reduced from 130.7% to 55% over the past 5 years.

Debt Coverage: HOLX's debt is well covered by operating cash flow (39.8%).

Interest Coverage: HOLX earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.